Challenges of managing elderly men with prostate cancer.

about

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions.Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts.

P2860

Q37538483-7B9EB1F3-D3C6-4C28-B88E-992408228A1A Q40459123-FDC84E11-9A0D-40CF-964B-A1EC61AF74B6

P2860

Challenges of managing elderly men with prostate cancer.

Item

http://www.wikidata.org/entity/Q38211358

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Challenges of managing elderly men with prostate cancer.

@en

type

Item

label

Challenges of managing elderly men with prostate cancer.

@en

prefLabel

Challenges of managing elderly men with prostate cancer.

@en

P1476

Challenges of managing elderly men with prostate cancer.

@en

P2093

Ayman Soubra

http://www.w3.org/2001/XMLSchema#string

Badrinath R Konety

http://www.w3.org/2001/XMLSchema#string

Gautam G Jha

http://www.w3.org/2001/XMLSchema#string

Vidhu Anand

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Abiraterone in metastatic prostate cancer without previous chemotherapy

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Alpha emitter radium-223 and survival in metastatic prostate cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.

P2888

nrclinonc.2014.71

P304

354-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2014.71

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022636839

http://www.w3.org/2001/XMLSchema#string

P698

24821211

http://www.w3.org/2001/XMLSchema#string

P932

5788018

http://www.w3.org/2001/XMLSchema#string

Challenges of managing elderly men with prostate cancer.

about

P2860

P2860

Challenges of managing elderly men with prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932